La thrombose au cours des néoplasies myéloprolifératives - Influence de la mutation JAK2V617F
Med Sci (Paris), 35 8-9 (2019) 651-658
Published online: 2019-09-18
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Expression of CD4+T Cells in Myeloproliferative Diseases and the Effect of Ruxolitinib Treatment on Prognosis
Xiaoying Song, Siqi Dong, Yiping Yang, Cong Zhang, Jing Sun, Jun Zhang, Lichang Gao and Jianqiang LiuThe Tohoku Journal of Experimental Medicine 263 (4) 271 (2024)
https://doi.org/10.1620/tjem.2024.J029
Thrombose porte : quand prescrire un traitement anticoagulant ?
Sarra Boukhris, Nabil Ben Chaabane, Nader Slama, et al.La Presse Médicale Formation 3 (3) 199 (2022)
https://doi.org/10.1016/j.lpmfor.2022.02.008
Hématomes surrénaliens non traumatiques : série rétrospective de 20 cas
N. Senni, M. Gerfaud-Valentin, A. Hot, et al.La Revue de Médecine Interne 42 (6) 375 (2021)
https://doi.org/10.1016/j.revmed.2021.03.009